Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Chikungunya Fever May Trigger Chronic Articular Symptoms

David Douglas  |  August 8, 2018

NEW YORK (Reuters Health)—More than half of those infected by the mosquito-borne Chikungunya virus will go on to experience chronic articular pain or arthritis, according to Brazilian researchers.

Chikungunya—meaning “to become contorted” in the Makonde language—was first described during an outbreak in Africa in the 1950s. Many outbreaks have since occurred in Africa, Asia and Europe, but it wasn’t until 2013 that the first autochthonous American case was documented, Dr. Fernando Edington and colleagues at Universidade Estadual de Santa Cruz note in Joint Bone Spine, online July 24.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The Pan American Health Organization reported in 2014 more than one million suspected cases of Chikungunya fever in the American continent in 2014. According to our data, 500,000 people (52% of the infected people) may have persisted with articular pain or arthritis for at least three months after the initial infection by Chikungunya virus,” Dr. Edington tells Reuters Health by email.

Dr. Edington and colleagues came to these conclusions after a systematic review and a meta-analysis of 18 studies conducted in the Americas between 2014 and 2018 involving 2,415 patients. The sample size ranged from 10 to 485 patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Overall, the study quality was deemed to be low and information on post-Chikungunya chronic symptoms were obtained via interviews in most cases. Only three studies evaluated the patients by means of clinical examination.

Follow-up ranged from 10 to 72 weeks and the pooled incidence of chronic articular symptoms in patients followed for more than 30 weeks was 54% compared to 52% in those with shorter follow-up. Incidence was similar with no significant differences across studies in South, Central and North America.

The researchers observe that despite the high incidence of these symptoms there is no specific treatment “besides hydration and analgesics.”

“The lack of transmission control,” Dr. Edington says, “the high incidence and economic burden associated with Chikungunya fever and its chronic forms should alert healthcare providers on the risks of new epidemics in the American continent.”


Reference

  1. Edington F, Varjão D, Melo P. Incidence of articular pain and arthritis after chikungunya fever in The Americas: A systematic review of the literature and meta-analysis. Joint Bone Spine. 2018 Jul 24. pii: S1297-319X(18)30145-3. doi: 10.1016/j.jbspin.2018.03.019. [Epub ahead of print]

 

Share: 

Filed under:Conditions Tagged with:articular painarticular symptomschikungunyacontracted chikungunya virus

Related Articles

    Chikungunya: What Every Rheumatologist Needs to Know

    November 2, 2014

    How to spot, diagnose and treat this rapidly spreading mosquito-borne viral illness whose symptoms mimic arthritis

    Mosquito-Borne Chikungunya Virus Can Cause Long-Term Arthritis

    September 20, 2018

    Digital Images Studio / shutterstock.com Chikungunya is among a group of 16 diseases transmitted through mosquito, tick or flea bites that is of increasing public health concern in the U.S. Although few rheumatologists are likely to diagnose patients with the acute phase of the disease, they may encounter a handful of patients each year who…

    Chikungunya Virus May Lead to Long-Term Joint Pain

    November 18, 2020

    COVID-19 isn’t the only viral infection on the rise across the globe, so is chikungunya, which can cause arthritis-like symptoms and may lead to long-term joint pain.

    Experimental Drug Combination Curbs Chikungunya Arthritis in Mice

    May 16, 2017

    fi3/shutterstock.com Doctors have had few options to treat the chronic rheumatoid arthritis-like symptoms associated with chikungunya virus infections beyond over-the-counter pain relievers. A recent study in Science Translational Medicine has spurred new optimism by finding that a combination therapy—the anti-rheumatic drug abatacept paired with a chikungunya-neutralizing monoclonal antibody—abolished acute symptoms in infected mice.1 The strategy…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences